Drugs that contain Iloperidone

1. List of Fanapt drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9138432 VANDA PHARMS INC Methods for the administration of iloperidone
Sep, 2025

(2 years from now)

US8586610 VANDA PHARMS INC Methods for the administration of iloperidone
Nov, 2027

(4 years from now)

US9157121 VANDA PHARMS INC Method of treatment based on polymorphisms of the KCNQ1 gene
Apr, 2030

(7 years from now)

US8652776 VANDA PHARMS INC Prediction of QT prolongation based on SNP genotype
Aug, 2030

(7 years from now)

US8999638 VANDA PHARMS INC Method of treatment based on polymorphisms of the KCNQ1 gene
Oct, 2030

(7 years from now)

US9074255 VANDA PHARMS INC Method of predicting a predisposition to QT prolongation
Dec, 2030

(7 years from now)

US9072742 VANDA PHARMS INC Method of predicting a predisposition to QT prolongation
Jan, 2031

(7 years from now)

US9074256 VANDA PHARMS INC Method of predicting a predisposition to QT prolongation
Feb, 2031

(8 years from now)

US9074254 VANDA PHARMS INC Method of predicting a predisposition to QT prolongation
Dec, 2031

(8 years from now)

Market Authorisation Date: 06 May, 2009

Treatment: Method of treating schizophrenia by administering iloperidone to a patient by reducing the dose in patients who are being treated with fluoxetine; Method of treating schizophrenia by administering iloperidone to a patient by reducing the dose in patients who are poor metabolizers of cyp2d6; Dosage modification to reduce risks associated with qt prolongation not induced by other drugs during treatment with iloperidone; Dosage modification to reduce the risk associated with qt prolongation not induced by other drugs during treatment with iloperidone

Dosage: TABLET;ORAL

How can I launch a generic of FANAPT before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic